Recovery of oxidative stress-induced damage in Cisd2-deficient cardiomyocytes by sustained release of ferulic acid from injectable hydrogel
Journal
Biomaterials
Journal Volume
103
Pages
207-218
Date Issued
2016
Author(s)
Cheng, Y.-H.
Lin, F.-H.
Wang, C.-Y.
Hsiao, C.-Y.
Chen, H.-C.
Kuo, H.-Y.
Tsai, T.-F.
Chiou, S.-H.
Abstract
Aging-related oxidative stress is considered a major risk factor of cardiovascular diseases (CVD) and could be associated with mitochondrial dysfunction and reactive oxygen species (ROS) overproduction. Cisd2 is an outer mitochondrial membrane protein and plays an important role in controlling the lifespan of mammals. Ferulic acid (FA), a natural antioxidant, is able to improve cardiovascular functions and inhibit the pathogenetic CVD process. However, directly administering therapeutics with antioxidant molecules is challenging because of stability and bioavailability issues. In the present study, thermosensitive chitosan-gelatin-based hydrogel containing FA was used to treat Cisd2-deficient (Cisd2?/?) cardiomyocytes (CM) derived from induced pluripotent stem cells of Cisd2?/? murine under oxidative stress. The results revealed that the developed hydrogel could provide a sustained release of FA and increase the cell viability. Post-treatment of FA-loaded hydrogel effectively decreased the oxidative stress-induced damage in Cisd2?/? CM via increasing catalase activity and decreasing endogenous reactive oxygen species (ROS) production. The in?vivo biocompatibility of FA-loaded hydrogel was confirmed in subcutaneously injected rabbits and intramyocardially injected Cisd2?/? mice. These results suggest that the thermosensitive FA-loaded hydrogel could rescue Cisd2?/? CM from oxidative stress-induced damage and may have potential applications in the future treatment of CVD. ? 2016 Elsevier Ltd
Subjects
Chitosan; Cisd2; Ferulic acid; Hydrogel; Mitochondria
SDGs
Other Subjects
Antioxidants; Biochemistry; Biocompatibility; Biological membranes; Cell membranes; Chitin; Chitosan; Mammals; Mitochondria; Oxidative stress; Stem cells; Cardiovascular function; Cisd2; Ferulic acids; Induced pluripotent stem cells; Mitochondrial dysfunction; Outer mitochondrial membranes; Reactive oxygen species; Vivo biocompatibilities; Hydrogels; catalase; chitosan; Cisd2 protein; ferulic acid; gelatin; outer membrane protein; reactive oxygen metabolite; unclassified drug; antioxidant; carrier protein; coumaric acid; ferulic acid; nerve protein; nonsteroid antiinflammatory agent; Noxp70 protein, mouse; reactive oxygen metabolite; albino rabbit; animal cell; animal experiment; animal model; animal tissue; antioxidant activity; Article; biocompatibility; C57BL 6 mouse; cardiac muscle cell; cell damage; cell viability; chemoluminescence; controlled study; drug cytotoxicity; drug efficacy; embryo; enzyme activity; flow measurement; heart protection; hydrogel; in vitro study; in vivo study; induced pluripotent stem cell; male; mouse; nonhuman; oxidative stress; priority journal; scanning electron microscopy; sustained drug release; treatment outcome; administration and dosage; animal; cardiac muscle cell; cell culture; chemistry; delayed release formulation; drug effects; hydrogel; injection; knockout mouse; metabolism; oxidative stress; physiology; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carrier Proteins; Cells, Cultured; Coumaric Acids; Delayed-Action Preparations; Hydrogels; Injections; Mice; Mice, Knockout; Myocytes, Cardiac; Nerve Tissue Proteins; Oxidative Stress; Reactive Oxygen Species
Type
journal article